The NFL and the NFLPA agreed on July 25 that the new CBA will include annual and random testing for HGH. Given an inability to agree on how the testing will occur, the program won’t be launched before the start of the season.
Mark Maske of the Washington Post reports that the league has informed the owners that HGH testing won’t be implemented to start the regular season.
“Although the CBA reflects a commitment to implement [HGH] testing by the start of the 2011 regular season, it is apparent that we will be unable to do so because of the Union’s continued refusal to accept the validity of the tests developed by the World Anti-Doping Agency that are used in Olympic sports and minor league baseball,” NFL general counsel Jeff Pash wrote in a memo obtained by Maske.
The NFLPA continues to express reservations regarding the testing procedures to be used by the World Anti-Doping Agency, possibly taking a page from their CBA playbook by claiming that more information is needed. Either way, the players agreed to HGH testing, and now they must in good faith agree to a specific testing method. If the players don’t like the World Anti-Doping Agency’s proposed protocol, then the NFLPA needs to offer up an alternative.
Until then, the message to players continues to be: “Inject ’em if you got ’em.”